Covalis Capital’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
LP
PF
AGC
AC
FTCM
SCM
SAMU
Covalis Capital's FSNB.WS Position: Q1 2022 in Review
Covalis Capital sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q1 2022, closing a stake of 166,666 shares — an estimated $659K sold.
Covalis Capital first reported a position in FSNB.WS in Q2 2021 and held it in 3 quarters. The position peaked at $740K in Q2 2021. 68 funds tracked by Wall St. Rank hold FSNB.WS as of Q1 2022.
- Covalis Capital reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
- Covalis Capital sold 166,666 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q1 2022, an estimated $659K.
- Covalis Capital first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 3 quarters.
- Covalis Capital's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $740K in Q2 2021.
- 68 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q1 2022.
Based on Covalis Capital's 13F filing for Q1 2022, filed 16 May 2022.